Essen Biotech
Clinical trials sponsored by Essen Biotech, explained in plain language.
-
Off-the-Shelf immune cell therapy trial opens for tough cancers
Disease control Recruiting nowThis study is testing a new type of immune cell therapy called EBNK-001 for people with advanced solid tumors that have stopped responding to standard treatments. Participants receive 'off-the-shelf' natural killer (NK) cells from a donor after a short course of chemotherapy, wit…
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Personalized cell therapy trial offers new hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new type of cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors will analyze a patient's tumor to select a specific target, then infuse specially engineered immune cells (CAR-NK cells) from a heal…
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC